Impact Therapeutics' (HKG:7630) shares opened 76.6% above their initial public offering price in a solid Hong Kong debut on Wednesday morning.
The Chinese biotech company opened at HK$35.50 per share, compared with the offer price of HK$20.10.
Impact Therapeutics' (HKG:7630) shares opened 76.6% above their initial public offering price in a solid Hong Kong debut on Wednesday morning.
The Chinese biotech company opened at HK$35.50 per share, compared with the offer price of HK$20.10.
Comments